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Oral cavity diseases are the most common 
diseases in the world and aren’t only a medical but also 
social problem. To date, among patients of different age 
groups there is a high incidence of periodontal tissue and 
mucous membranes diseases, which worsen the health of 
other organs and reduce the quality of socio-psychological 
life [1, 2]. The list of complications caused by periodontal 
diseases, first of all, includes inflammatory processes of the 
maxillofacial area, digestive disorders, compromised 
resistance to infectious and other agents [3]. This, in turn, 
requires appropriate treatment, which is mainly based on 
the use of topical drugs [4, 5]. 
According to the analysis of scientific literature, 
the most common topical dosage form in dental practice is 
gel, which combines the properties of solid and liquid 
forms, and therefore is easy to use and effective in 
applications [6-8].  
At the Industrial Technology of Drugs 
Department of National University of Pharmacy, two 
dental gels are being developed under the name 
"Cholident" and "Lysostom", which contain carbopol and 
hydroxyethylcellulose as gelling agents respectively, and 
purified water as a solvent. It is known that hydrophilic 
bases provide a uniform distribution of the gel on oral 
mucosa and contribute to effective therapeutic effect of 
active pharmaceutical ingredients (API), however, at the 
same time, they are prone to microbial contamination [9]. 
In addition, the developed drugs contain API of natural 
origin, which are also a favorable environment for the 
multiplying of microorganisms [10]. 
Previous studies showed that freshly prepared gels 
satisfied the requirements of SPhU for microbiological 
purity [15]. However contamination of the samples by test-
microorganisms caused their intensive growth, which 
proved necessity for introduction of antimicrobial 
preservatives into the gels. These adjuvants prolong the 
shelf life of pharmaceutical products, increase their 
resistance to spoilage after opening the package, especially 
in the case of using multi-dose containers, and, 
accordingly, prevent infection of the patient [12-14]. 
Therefore, the aim of this work was selection of 
effective antimicrobial preservatives in rational 
concentrations for the composition of dental gels 
"Cholident" and "Lysostom". 
  
Materials & methods  
The composition and characteristics of the 
components of gels "Cholident" and "Lysostom" are 
presented in Table 1. 
Table 1. The composition of dental gels are being developed 
Name of ingredient Manufacturer Role in drug composition 
Gel "Cholident" 
Tincture "Phytodent" PJSC «CPP Chervona zirka», Ukraine API 
Choline salicylate 80 %  Basf Pharma, Switzerland API 
Lidocaine hydrochloride Societa Italiana Medicinali Scandicci, Italy API 
Carbopol Polacril® 40P Amedeo Brasca & C. Srl, Italy gelling agent 
Sodium hydroxide  
(10 % solution )  
Chemical reagents, Ukraine neutralizer 
OraRez® W-100L16 BOAI, China mucosal adhesive 
Purified water   solvent 
Gel "Lysostom" 
Lysozyme hydrochloride Bouwhuis Enthoven B.V., Netherlands API 
Hydroxyethylcellulose 
Natrosol™ 250HHX 
Ashland, Holland gelling agent 
Glycerol BASF, Germany 
hydrophilic non-aqueous solvent 
(plasticizer, humidifier, 
adhesive) 
Purified water   solvent 
 
The following ingredients were selected as 
preservatives in the gels are being developed: benzoic acid, 
sodium benzoate, sorbic acid, potassium sorbate, methyl 
parahydroxybenzoate (nipagin), propyl 
parahydroxybenzoate (nipazol). The concentration of 
preservatives for all gel samples was 0.1 % and 0.2 % [12-
14]. 
The implantation of selected preservatives in 
composition of the gel "Cholident" was carried out taking 
into account their solubility: benzoic acid, sorbic acid and 
nipagin : nipazol were dissolved in alcohol tincture 
"Phytodent"; potassium sorbate and sodium benzoate – in 
purified water. Nipagin and nipazol were used in a ratio of 
3:1 to expand the antimicrobial action on both bacteria and 
fungi. 
For the preparation of gel "Lysostom", potassium 
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sorbate and sodium benzoate were dissolved in purified 
water at room a temperature, and nipagin – at a temperature 
of 80 °C. Adding of benzoic and sorbic acids to the gel 
caused denaturation of lysozyme hydrochloride and 
forming of a white precipitate, so these preservatives were 
excluded from the experiment. Nipazol due to its very poor 
solubility in water [12, 14] was also not used. 
The selection of preservative for the composition 
of dental gels "Cholident" and "Lysostom" was based on 
the study of its antimicrobial activity. Preservatives 
effectiveness tests were carried out according to the 
method of SPhU 2.3, Ch. 5.1.3 [15]. 
In order to test the effectiveness of selected 
antimicrobial preservatives, each container with a gel 
sample was inoculated by freshly prepared suspension with 
one of the test-microorganisms, while providing a 
microbial load of 105 CFU to 106 CFU in 1 ml of the 
sample, stirred thoroughly for even distribution in the gel 
sample and stored at temperature 20-25 С in a dark place. 
Immediately after inoculation and at regular intervals 
(drugs for oral administration after 14 and 28 days), 1 ml 
was taken from each sample and a number of viable 
microorganisms was determined by surface sowing on 
dishes. The criterion for preservative effectiveness 
evaluation was a reduction of the number of viable test-
microorganisms in the drug for a certain period of time 
after its contamination. According to the requirements of 
SPhU, the logarithm of decrease in the number of viable 
bacterial cells after 14 days should be at least three with no 
further increase in quantity of microorganisms; the 
logarithm of decrease in the number of viable fungal cells 
after 14 days should be at least one, in the future the 
number of viable fungal cells shouldn’t increase [15]. 
As a bacterial test-culture Staphylococcus aureus 
ATCC 6538, Pseudomonas aeruginosa ATCC 9027, 
Candida albicans ATCC 10231, Aspergillus brasiliensis 
ATCC 16404 and Escherichia coli ATCC 8739 (last one is 
recommended in studies for oral drugs) were used; 
inoculum preparation was performed according to SPhU 
[15]. 
According to the requirements of SPhU, the 
sterility test of culture medium and solvent: growth 
properties of culture medium (soy-casein culture medium 
– for bacterial cells growth and Saburo-dextrose medium 
without antibiotics – for fungal cells) and suitability test of 
methods for determining the total number of cells were 
performed. 
As a control in determining the growth qualities 
of the culture medium was a standard medium with pre-
established growth properties, which correctly manifests 
the quantitative and qualitative growth of microorganisms 
(morphology of colonies). Culture medium satisfied the 
growth properties and sterility test according to SPhU 
requirements [11], and the test-microorganisms met 
taxonomic characteristics – morphology of the colonies on 
the medium and morphology of cells under microscopy 
were typical for the strain.  
Suitability of the method for determining the total 
number of viable cells was carried out by comparing the 
number of test-microorganisms of the test drug and control 
inoculations. The antimicrobial activity of the drug was 
eliminated by dilution. Suitability of the method for 
determining the total viable microorganisms was tested in 
the drug samples diluted 1:10 by solvent buffer solution of 
sodium chloride and peptone pH = 7.0 with 5 % 
polysorbate-80, 0.5 % lecithin and 0.1 % histidine 
hydrochloride. The method of surface inoculation with 
samples diluted 1:10 and using a typical neutralizing 
solvent is suitable for determining the number of 
microorganisms in the samples and can be used for 
antimicrobial drug’s effectiveness test. 
  
Results & discussions  
Drugs or their individual components can inhibit 
the growth of contaminating microorganisms. Determining 
the presence or absence of antimicrobial action and its 
neutralization is an important part of the preparatory work 
before the study of the drug [16]. Previous studies have 
shown moderate antibacterial and fungicidal activity for 
"Cholident" gel [17] and for "Lysostom" gel [18], but even 
if no increase in the number of viable cells was observed 
during the development period, during storage gel samples 
without preservatives didn't meet the requirements of 
microbiological purity of SPhU criteria for oral aqueous 
preparations [15]. Therefore, in order to effectively protect 
the drug from microbial contamination during storage and 
use, samples of gels with preservatives were prepared. 
It's known that selection of preservatives and their 
dosage depends on: degree of bacterial contamination and 
qualitative composition of the microflora; conditions of 
production and storage; chemical composition of the 
product and its physicochemical properties; expected shelf 
life. In addition, the development of dental gels should take 
into account compatibility of the preservative with API, 
potential for oral use and its safety [19]. 
Results of the effectiveness study of selected 
antimicrobial preservatives in the gel "Lysostom" are 
presented in Table 2. 









lg reduction of viable 
microorganisms number, 
lg CFU/ml 
(SPhU requirements 2.3 / results 
obtained) 




0.1 5.28 3/3.22 NI/ND 
0.2 5.34 3/ND NI/ND 
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0.1 5.58 3/3.68 NI/ND 
0.2 5.51 3/3.95 NI/ND 
Escherichia coli 
ATCC 8739 
0.1 5.60 3/ND NI/ND 
0.2 5.58 3/ND NI/ND 
Candida albicans 
ATCC 10231 
0.1 5.58 1/3.04 NI/ND 
0.2 5.58 1/4.18 NI/ND 
Aspergillus brasiliensis 
ATCC 16404 
0.1 5.58 1/2.84 NI/ND 




0.1 5.32 3/ND NI/ND 
0.2 5.28 3/ND NI/ND 
Pseudomonas aeruginosa  
ATCC 9027 
0.1 5.54 3/3.84 NI/ND 
0.2 5.48 3/ND NI/ND 
Escherichia coli 
ATCC 8739 
0.1 5.60 3/ND NI/ND 
0.2 5.56 3/ND NI/ND 
Candida albicans 
ATCC 10231 
0.1 5.57 1/3.57 NI/ND 
0.2 5.60 1/ND NI/ND 
Aspergillus brasiliensis  
ATCC 16404 
0.1 5.65 1/3.20 NI/ND 




0.1 5.30 3/3.12 NI/ND 
0.2 5.36 3/3.30 NI/ND 
Pseudomonas aeruginosa  
ATCC 9027 
0.1 5.57 3/3.55 NI/ND 
0.2 5.44 3/3.71 NI/ND 
Escherichia coli 
ATCC 8739 
0.1 5.58 3/3.18 NI/ND 
0.2 5.52 3/3.46 NI/ND 
Candida albicans 
ATCC 10231 
0.1 5.60 1/2.41 NI/ND 
0.2 5.62 1/4.14 NI/ND 
Aspergillus brasiliensis  
ATCC 16404 
0.1 5.60 1/2.60 NI/ND 
0.2 5.62 1/ND NI/ND 
Notes: NI – no increase in the number of microorganisms compared to the number of viable microorganisms at 
the previous control point; ND – no viable cells of microorganisms were detected in the experiment. 
 
The results presented in Table 2, indicate that after 
14 days of storage of inoculated samples of gel "Lysostom" 
with preservative nipagin a lg reduction of viable 
microorganisms was more than 3.0 and was 3.22 for 
Staphylococcus aureus at a concentration 0.1 %, 3.68 for 
Pseudomonas aeruginosa; for Escherichia coli – viable 
bacterial microorganisms were not detected; at a 
concentration of 0.2 % viable cells were not registered for 
Staphylococcus aureus and Escherichia coli, and for 
Pseudomonas aeruginosa lg was equal to 3.95. For 
Candida albicans cells on day 14, the lg reduction of 
bacterial cells number in samples with nipagin 0.1 % was 
3.04 (minimum according to requirements – 1.0), nipagin 
0.2 % – 4.18. For culture of Aspergillus brasiliensis on day 
14 with nipagin 0.1 % lg reduction was 2.84, however, in 
samples of gel with nipagin 0.2 % fungal cells were not 
detected. On day 28, viable bacterial and fungal cells were 
not detected in gel samples with a concentration of nipagin 
0.1 % and 0.2 %. 
For samples of "Lysostom" gel with preservative 
sodium benzoate 0.1 % and 0.2 % after 14 days of storage 
Staphylococcus aureus and Escherichia coli were not 
registered in any case, and lg reduction in number of 
bacteria Pseudomonas aeruginosa was 3.84 at a 
concentration of 0.1 %, and bacterial cells were not 
detected at 0.2 %. As of fungi colonies, in 14 days lg 
reduction of Candida albicans was 3.57 with 0.1 % sodium 
benzoate and no bacterial cells were found with 
concentration of preservative 0.2 %. A similar trend was 
observed for the fungus Aspergillus brasiliensis: at 0.1 % 
lg reduction was 3.20, and at 0.2 % – no microorganisms 
were detected. On the 28th day of the experiment, the cells 
of the test-microorganisms were not detected.  
Based on the results of Table 2, samples of 
"Lysostom" gel with potassium sorbate in the amount of 
0.1 % and 0.2 % also showed antimicrobial activity against 
test-microorganisms. Thus, on the 14th day lg reduction of 
bacterial cells number Staphylococcus aureus was 3.12 
(potassium sorbate 0.1%) and 3.30 (potassium sorbate 
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0.2 %), Pseudomonas aeruginosa – 3.55 (potassium 
sorbate 0.1 %) and 3.71 (potassium sorbate 0.2 %), 
Escherichia coli – 3.18 (potassium sorbate 0.1 %) and 3.46 
(potassium sorbate 0.2 %), which exceeds the requirements 
of SPhU. For fungi, the results were: lg reduction of 
Candida albicans cells was 2.41 and 4.14, respectively, at 
concentrations of 0.1 % and 0.2 % of potassium sorbate in 
the gel sample, and for Aspergillus brasiliensis – 2.60 at a 
concentration of 0.1 % and were not detected at 0.2 % of 
potassium sorbate. On the 28th day of the experiment, cells 
of the test-microorganisms were not detected. Thus, the 
effectiveness of the preservative potassium sorbate in both 
concentrations in composition of the gel "Lysostom" meets 
the requirements of SPhU.  
Summarizing the results of Table 2 for dental gel 
"Lysostom" with preservatives nipagin, sodium benzoate, 
potassium sorbate, it could be noted that the obtained data 
satisfy the requirements of SPhU for oral drugs. Among the 
preservatives listed above, sodium benzoate at a 
concentration of 0.2 % had the highest antimicrobial 
activity. 
In the Table 3 presented the results of study of 
selected antimicrobial preservatives effectiveness in the 
composition of the gel "Cholident".  
 








lg reduction of viable 
microorganisms number, 
lg CFU/ml 
(SPhU requirements 2.3 / results 
obtained) 
14 days 28 days 
Nipagin : nipazol (3:1) 
Staphylococcus aureus 
ATCC 6538 
0.1 5.38 3/ND NI/ND 




0.1 5.54 3/4.05 NI/ND 
0.2 5.58 3/4.18 NI/ND 
Escherichia coli 
ATCC 8739 
0.1 5.58 3/ND NI/ND 
0.2 5.60 3/ND NI/ND 
Candida albicans 
ATCC 10231 
0.1 5.56 1/3.22 NI/ND 




0.1 5.56 1/ND NI/ND 




0.1 5.18 3/3.52 NI/ND 




0.1 5.54 3/3.86 NI/ND 
0.2 5.59 3/3.94 NI/ND 
Escherichia coli 
ATCC 8739 
0.1 5.58 3/ND NI/ND 
0.2 5.54 3/ND NI/ND 
Candida albicans 
ATCC 10231 
0.1 5.61 1/3.08 NI/ND 




0.1 5.65 1/2.00 NI/ND 




0.1 5.30 3/3.28 NI/ND 




0.1 5.57 3/3.42 NI/ND 
0.2 5.59 3/3.48 NI/ND 
Escherichia coli 0.1 5.54 3/3.59 NI/ND 
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ATCC 8739 0.2 5.52 3/3.62 NI/ND 
Candida albicans 
ATCC 10231 
0.1 5.62 1/2.95 NI/ND 




0.1 5.60 1/1.83 NI/ND 




0.1 5.26 3/3.56 NI/ND 




0.1 5.56 3/3.86 NI/ND 
0.2 5.54 3/4.06 NI/ND 
Escherichia coli 
ATCC 8739 
0.1 5.60 3/ND NI/ND 
0.2 5.57 3/ND NI/ND 
Candida albicans 
ATCC 10231 
0.1 5.60 1/3.11 NI/ND 




0.1 5.57 1/2.09 NI/ND 




0.1 5.34 3/3.49 NI/ND 




0.1 5.58 3/3.45 NI/ND 
0.2 5.58 3/3.88 NI/ND 
Escherichia coli 
ATCC 8739 
0.1 5.56 3/3.61 NI/ND 
0.2 5.54 3/ND NI/ND 
Candida albicans 
ATCC 10231 
0.1 5.59 1/3.0 NI/ND 




0.1 5.59 1/1.89 NI/ND 
0.2 5.64 1/1.95 NI/ND 
Notes: NI – no increase in the number of microorganisms compared to the number of viable microorganisms at the 
previous control point; ND – no viable cells of microorganisms were detected in the experiment. 
 
 
Analyzing the obtained data presented in Table 3 
of gel "Cholident" samples with a combination of 
preservatives nipagin : nipazol (3:1) in concentrations 
0.1 % and 0.2 %, after 14 days of cultivation lg reduction 
of bacterial cells number was more than 3. Staphylococcus 
aureus and Escherichia coli cells were not detected at both 
concentrations, and for Pseudomonas aeruginosa lg 
reduction of cells number was 4.05 and 4.18 at 0.1 % and 
0.2 % respectively. For fungi, this figure was greater than 
1 and equal to 3.22 at a concentration 0.1 % for Candida 
albicans cells; at concentration 0.2 %, no microorganisms 
were detected, as for both concentrations in experiments 
with Aspergillus brasiliensis. On the 28th day of 
incubation, the test-microorganisms cells were not 
detected.  
The results of study of gel "Cholident" with 
preservatives sodium benzoate and potassium benzoate 
proved that on the 14th day of storage of inoculated 
samples lg reduction of bacterial cells number was more 
than 3 and didn't grow significantly with an increase of 
preservatives concentration. Thus, for Staphylococcus 
aureus this indicator was 3.52 and 3.65 (sodium benzoate 
0.1 % and 0.2 %, respectively), 3.28 and 3.37 (potassium 
sorbate 0.1 % and 0.2 %, respectively); for Pseudomonas 
aeruginosa – 3.86 and 3.94 (sodium benzoate 0.1 % and 
0.2 %, respectively), 3.42 and 3.48 (potassium sorbate 
0.1 % and 0.2 % respectively); for Escherichia coli, no 
viable cells were detected in the sodium benzoate samples, 
and for potassium sorbate, the lg reduction of cells quantity 
was 3.59 (potassium sorbate 0.1 %) and 3.62 (potassium 
sorbate 0.2 %). For the fungi Candida albicans lg 
reduction of the cells number was 3.08 and 3.14 in samples 
with sodium benzoate in concentrations of 0.1 % and 0.2%, 
respectively, and 2.95 and 3.00 in samples with potassium 
sorbate 0,1 % and 0.2 %, respectively. On the 28th day of 
storage of inoculated gel samples, test-microorganisms 
were not detected.  
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A similar trend was observed for samples of gel 
"Cholident" with preservatives benzoic acid and sorbic 
acid – lg reduction of bacterial cells number was more than 
3, fungi cells – over 1. On the 14th day of inoculation, this 
value for Staphylococcus aureus was 3.56 and 3.49 for 
samples with acids at a concentration 0.1 %; at a 
concentration of 0.2 % – cells were not detected. As of 
Pseudomonas aeruginosa – 3.86 and 4.06 (benzoic acid 
0.1 % and 0.2 %, respectively), 3.45 and 3.88 (sorbic acid 
0.1 % and 0.2 %, respectively). Escherichia coli was not 
detected in samples with benzoic acid; for sorbic acid in a 
concentration of 0.1 % this indicator was 3.61, and at 0.2 % 
– microorganisms were not detected. For fungi Candida 
albicans – 3.11 (benzoic acid 0.1 %); cells were not 
detected (benzoic acid 0.2 %) and 3.00 and 3.56 (sorbic 
acid 0.1 % and 0.2 %, respectively), and for Aspergillus 
brasiliensis – 2.09 (benzoic acid 0.1 %) and the cells were 
not detected (benzoic acid 0.2 %), 1.89 and 1.95 (sorbic 
acid 0.1 % and 0.2 %, respectively). On the 28th day of the 
experiment, the test-microorganisms cells were not 
detected. 
Thus, the results of antimicrobial preservatives 
efficacy determination in the composition of the dental gel 
"Cholident" (Table 3) proved SPhU eligibility for all 
samples. The combination of nipagin : nipazol had the 
highest antimicrobial activity against all test-
microorganisms, and, taking into account the requirements 
of economy and safety, their use at a concentration of 0.1 % 




1. Tests of the antimicrobial preservatives effectiveness in 
the experimental samples of dental gels "Lysostom" and 
"Cholident" proved that all the studied preservatives, 
namely sodium benzoate, potassium sorbate, nipagin and 
combination nipagin with nipazol, benzoic acid and sorbic 
acid, had high antimicrobial efficacy and met the 
requirements of SPhU for oral drugs. 
2. Taking into account a slightly higher antimicrobial 
activity, the sodium benzoate at a concentration 0.2 % was 
selected as the most acceptable preservative for the gel 
"Lysostom". The combination nipagin : nipazol (3:1) was 
chosen as the most promising preservative for the gel 
"Cholident", which provided at a concentration 0.1 % 
stronger than other preservatives antimicrobial action. 
These measures will ensure the safety of the drugs during 
storage and use. 
 
Testing of antimicrobial activity of preservatives for 
dental gels development 
Maslii Yu. S., Ruban O. A, Kaliuzhnaia O. S., 
Khokhlenkova N. V 
Introduction. Given the widespread prevalence of oral 
diseases, especially pathologies of periodontal tissues and 
mucous membranes, among the population of different 
ages and the needs of the pharmaceutical market in 
topical drugs for their treatment, the development of new 
domestic dental drugs is relevant. The most common 
topical dosage form in dental practice is gels, which are 
characterized by good distribution on the tissues of the 
oral cavity, prolonging effect and high bioavailability. At 
the Industrial Technology of Drugs Department of 
National University of Pharmacy, two dental gels are 
being developed under the name "Cholident" and 
"Lysostom". Previous studies showed that freshly 
prepared gels satisfied the requirements of SPhU for 
microbiological purity. However, contamination of the 
samples by test-microorganisms caused their intensive 
growth, which proved necessity for introduction of 
antimicrobial preservatives into the gels. These adjuvants 
prolong the shelf life of pharmaceutical products, increase 
their resistance to spoilage after opening the package, 
especially in the case of using multi-dose containers, and, 
accordingly, prevent infection of the patient. The aim of 
this work was selection of effective antimicrobial 
preservatives in rational concentrations for the 
composition of dental gels "Cholident" and "Lysostom". 
Materials & methods. The following ingredients were 
selected as preservatives in the gels are being developed: 
benzoic acid, sodium benzoate, sorbic acid, potassium 
sorbate, methyl parahydroxybenzoate (nipagin), propyl 
parahydroxybenzoate (nipazol). The concentration of 
preservatives for all gel samples was 0.1 % and 0.2 %. 
They have much lower toxicity than others, are harmless 
to humans even in large quantities and are permitted for 
the preservation of food and pharmaceutical products. The 
selection of preservative for the composition of dental 
gels "Cholident" and "Lysostom" was based on the study 
of its antimicrobial activity. Preservatives effectiveness 
tests were carried out according to the method of SPhU 
2.3, Ch. 5.1.3.  According to the requirements of SPhU, 
the sterility test of culture medium and solvent: growth 
properties of culture medium (soy-casein culture medium 
– for bacterial cells growth and Saburo-dextrose medium 
without antibiotics – for fungal cells) and suitability test 
of methods for determining the total number of cells were 
performed. Results & discussion. Tests have shown that 
for dental gel "Lysostom" with preservatives nipagin, 
sodium benzoate, potassium sorbate, it could be noted that 
the obtained data satisfy the requirements of SPhU for 
oral drugs. Among the preservatives listed above, sodium 
benzoate at a concentration of 0.2 % had the highest 
antimicrobial activity. The results of antimicrobial 
preservatives efficacy determination in the composition of 
the dental gel "Cholident" proved SPhU eligibility for all 
samples. The combination of nipagin : nipazol had the 
highest antimicrobial activity against all test-
microorganisms, and, taking into account the 
requirements of economy and safety, their use at a 
concentration of 0.1 % will be sufficient. Conclusion. 
Thus, tests of the antimicrobial preservatives 
effectiveness in the experimental samples of dental gels 
"Lysostom" and "Cholident" proved that all the studied 
preservatives, namely sodium benzoate, potassium 
sorbate, nipagin and combination nipagin with nipazol, 
benzoic acid and sorbic acid, had high antimicrobial 
efficacy and met the requirements of SPhU for oral drugs. 
Taking into account a slightly higher antimicrobial 
activity, the sodium benzoate at a concentration 0.2 % 
was selected as the most acceptable preservative for the 
gel "Lysostom". The combination nipagin : nipazol (3:1) 
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was chosen as the most promising preservative for the gel 
"Cholident", which provided at a concentration 0.1 % 
stronger than other preservatives antimicrobial action.  
Key words: dental gel, preservative, 
microbiological studies, antimicrobial activity 
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